CM
PTCT icon

Caption Management’s PTC Therapeutics PTCT Stock Holding History

Caption Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,300
Closed -$193K – 1529
2024
Q2 		$193K Buy
+6,300
New +$204K ﹤0.01% 956
2023
Q4 		– Sell
-2,119
Closed -$48.5K – 1600
2023
Q3 		$47.5K Sell
2,119
-22,599
-91% -$840K ﹤0.01% 1189
2023
Q2 		$1.01M Buy
+24,718
New +$1.21M 0.02% 663
2022
Q3 		– Sell
-5,000
Closed -$245K – 1780
2022
Q2 		$200K Buy
+5,000
New +$175K ﹤0.01% 1238
2021
Q4 		– Sell
-263
Closed -$10.1K – 1865
2021
Q3 		$10K Buy
+263
New +$10.8K ﹤0.01% 1449
2020
Q3 		– Sell
-24,400
Closed -$1.2M – 1210
2020
Q2 		$1.24M Sell
24,400
-60,762
-71% -$2.99M 0.04% 483
2020
Q1 		$3.8M Sell
85,162
-23,838
-22% -$1.2M 0.21% 138
2019
Q4 		$5.24M Buy
109,000
+69,000
+173% +$2.93M 0.18% 151
2019
Q3 		$1.35M Buy
+40,000
New +$1.74M 0.07% 317
2019
Q1 		– Sell
-15,000
Closed -$504K – 699
2018
Q4 		$514K Buy
+15,000
New +$539K 0.04% 333
2018
Q3 		– Sell
-22,500
Closed -$931K – 621
2018
Q2 		$759K Buy
+22,500
New +$702K 0.06% 281

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Caption Management's PTCT Position: Q3 2024 in Review

Caption Management sold out of PTC Therapeutics (PTCT) in Q3 2024, closing a stake of 6,300 shares — an estimated $193K sold.

Caption Management first reported a position in PTCT in Q2 2018 and held it in 11 quarters. The position peaked at $5.24M in Q4 2019. 203 funds tracked by Wall St. Rank hold PTCT as of Q3 2024.

  • Caption Management reported no remaining PTC Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Caption Management sold 6,300 PTC Therapeutics shares in Q3 2024, an estimated $193K.
  • Caption Management first reported a position in PTC Therapeutics in Q2 2018 and held it in 11 quarters.
  • Caption Management's PTC Therapeutics position peaked at $5.24M in Q4 2019.
  • 203 funds tracked by Wall St. Rank held PTC Therapeutics as of Q3 2024.

Based on Caption Management's 13F filing for Q3 2024, filed 14 Nov 2024.